Many wellness centers provide these practices at low costs, making them accessible to those who need them most
BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
IGF-1 DES shows moderately reduced IGFBP affinity, with greater selectivity it particularly reduces affinity for IGFBP-1, IGFBP-2, and IGFBP-4, but retains more binding to IGFBP-3 than IGF-1 LR3 does
In June, AbbVie submitted applications for Rinvoq as a treatment for adults with active psoriatic arthritis and plans to file applications for two other additional indications, atopic dermatitis and ankylosing spondylitis, later this year
For daily prevention, stick to gentle osmotic hydration